acebutolol has been researched along with Cardiac Arrest, Sudden in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steriotis, AK | 1 |
| Nava, A | 1 |
| Rampazzo, A | 1 |
| Basso, C | 1 |
| Thiene, G | 1 |
| Daliento, L | 1 |
| Folino, AF | 1 |
| Rigato, I | 1 |
| Mazzotti, E | 1 |
| Beffagna, G | 1 |
| Carturan, E | 1 |
| Corrado, D | 1 |
| Bauce, B | 1 |
1 other study available for acebutolol and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
Follow-up with exercise test of effort-induced ventricular arrhythmias linked to ryanodine receptor type 2 gene mutations.
Topics: Acebutolol; Adolescent; Adult; Anti-Arrhythmia Agents; Cohort Studies; Death, Sudden, Cardiac; Echoc | 2012 |